Genetic variants in macrophage colony-stimulating factor are associated with risk of renal cell carcinoma in a Chinese population

被引:3
作者
Li, Xiao [1 ,2 ,3 ]
Qin, Zhiqiang [4 ]
Xue, Jianxin [4 ,5 ]
Zhang, Jianzhong [4 ]
Zheng, Yuxiao [4 ]
Xu, Weizhang [6 ,7 ]
Xu, Ting [1 ,2 ,3 ]
Zou, Qing [1 ,2 ,3 ]
机构
[1] Jiangsu Canc Hosp, Dept Urol, Nanjing, Jiangsu, Peoples R China
[2] Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China
[5] Southeast Univ, Dept Urol, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China
[6] Nanjing Med Univ, Affiliated Canc Hosp, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China
[7] Canc Inst Jiangsu Prov, Jiangsu Key Lab Mol & Translat Canc Res, Nanjing, Jiangsu, Peoples R China
关键词
CSF-I; genetic variants; renal cell carcinoma; susceptibility; BREAST-CANCER PROGRESSION; FACTOR-I; RECEPTOR; CSF-1; DIFFERENTIATION; POLYMORPHISMS; ENDOMETRIAL; EXPRESSION; PROGNOSIS; BIOLOGY;
D O I
10.1177/1724600817748879
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective: This study was performed to investigate whether CSF-I polymorphisms influenced the risk of renal cell carcinoma in a Chinese population. Methods: The potentially functional polymorphisms in CSF-I (rs333951 and rs2050462) were genotyped in this hospital-based case-control study, comprising 1512 renal cell carcinoma patients and 1691 controls in a Chinese population using the TaqMan assay. Furthermore, odds ratios (ORs) and 95% confidence intervals (CI) were used to estimate such an association. The logistic regression was used to assess the association between these genetic polymorphisms and the risk of renal cell carcinoma. Results: We found the genotype and allele frequency distribution of rs2050462 were significantly associated with the increasing risk of renal cell carcinoma (P = 0.007). However, no statistical significance was found in the association between CSF-I rs333951 polymorphism and the susceptibility of renal cell carcinoma (P = 0.589). The analysis of combined risk alleles revealed that patients with two to four risk alleles showed no elevated risk of renal cell carcinoma compared to those with zero to one risk alleles (adjusted OR 1.09; 95% CI 0.95, 1.26; P = 0.226). Furthermore, compared with the genotypes containing A allele (AC and AA), the patients carrying the CC genotype in rs2050462 had a significantly greater prevalence of clinical stage II and IV (adjusted OR 0.67; 95% CI 0.47, 0.94; P = 0.021; adjusted OR 0.50; 95% CI 0.29, 0.88; P = 0.015, respectively). Conclusions: The functional rs2050462 in CSF-I might have a substantial influence on the renal cell carcinoma susceptibility and evolution in the Chinese population.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 38 条
  • [1] Body size and renal cell cancer incidence in a large US cohort study
    Adams, Kenneth F.
    Leitzmann, Michael F.
    Albanes, Demetrius
    Kipnis, Victor
    Moore, Steven C.
    Schatzkin, Arthur
    Chow, Wong-Ho
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 168 (03) : 268 - 277
  • [2] HUMAN MACROPHAGE-COLONY STIMULATING FACTOR - ALTERNATIVE RNA AND PROTEIN PROCESSING FROM A SINGLE GENE
    CERRETTI, DP
    WIGNALL, J
    ANDERSON, D
    TUSHINSKI, RJ
    GALLIS, BM
    STYA, M
    GILLIS, S
    URDAL, DL
    COSMAN, D
    [J]. MOLECULAR IMMUNOLOGY, 1988, 25 (08) : 761 - 770
  • [3] The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis
    Cheungpasitporn, W.
    Thongprayoon, C.
    O'Corragain, O. A.
    Edmonds, P. J.
    Ungprasert, P.
    Kittanamongkolchai, W.
    Erickson, S. B.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2015, 108 (03) : 205 - 212
  • [4] Colony-stimulating factor-1 in immunity and inflammation
    Chitu, V
    Stanley, ER
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) : 39 - 48
  • [5] The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks
    Cumberbatch, Marcus G.
    Rota, Matteo
    Catto, James W. F.
    La Vecchia, Carlo
    [J]. EUROPEAN UROLOGY, 2016, 70 (03) : 458 - 466
  • [6] miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1
    Dang, Wei
    Qin, Zailong
    Fan, Songqing
    Wen, Qiuyuan
    Lu, Yuanjun
    Wang, Jia
    Zhang, Xuemei
    Wei, Lingyu
    He, Wei
    Ye, Qiurong
    Yan, Qun
    Li, Guiyuan
    Ma, Jian
    [J]. ONCOTARGET, 2016, 7 (22) : 32421 - 32432
  • [7] CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing
    Ding, Jingxian
    Guo, Chungen
    Hu, Pinghua
    Chen, Jun
    Liu, Qiuming
    Wu, Xiaobo
    Cao, Yali
    Wu, Jiong
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (05) : 2064 - 2074
  • [8] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [9] MACROPHAGE-COLONY-STIMULATING FACTOR STIMULATES SURVIVAL AND CHEMOTACTIC BEHAVIOR IN ISOLATED OSTEOCLASTS
    FULLER, K
    OWENS, JM
    JAGGER, CJ
    WILSON, A
    MOSS, R
    CHAMBERS, TJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1733 - 1744
  • [10] Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop
    Goswami, S
    Sahai, E
    Wyckoff, JB
    Cammer, N
    Cox, D
    Pixley, FJ
    Stanley, ER
    Segall, JE
    Condeelis, JS
    [J]. CANCER RESEARCH, 2005, 65 (12) : 5278 - 5283